Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Netcells is a leading South African biotechnology company specializing in the cryogenic preservation of umbilical cord blood and tissue stem cells. As a division of Next Biosciences, the company provides expectant parents with the opportunity to store their newborn's stem cells for potential future medical use in treating various blood-related and genetic disorders. Netcells operates an internationally accredited laboratory and is recognized as the longest-standing private stem cell bank in Africa. Beyond cord blood banking, the company offers related services such as newborn screening and genetic testing to support personalized healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Netcells Biosciences.